Posts

Assessment of Health-related Quality of Life in Different Phenotypes of COPD (article from 2017 Current Respiratory Medicine Reviews)

News alert: According to the last Pharma R&D 2017 Review, Respiratory Drugs the only group decreasing

The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease (2016 Expert Opinion on Drug Discovery)

Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD (full text article from NEJM 2016)